Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 2931
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT03459222 | An Investigational Study of Immunotherapy Combinations in Participants With Solid Cancers That Are Advanced or Have Spread | ||
| NCT00313300 | Safety Study of Apixaban in Recent Acute Coronary Syndrome | ||
| NCT03168464 | Radiation and Immune Checkpoints Blockade in Metastatic NSCLC (BMS # CA209-632) | ||
| NCT03660436 | An Investigational Study of Experimental Medication BMS-986165 in Healthy Participants | ||
| NCT04857034 | A Study to Evaluate Efficacy and Safety of Deucravacitinib in Participants With Active Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE) | ||
| NCT02350764 | Evaluate the Mediators of Sensitivity and Resistance to Nivolumab Plus Ipilimumab in Patients With Advanced NSCLCs | ||
| NCT02983006 | Study of DS-8273a With Nivolumab in Unresectable Stage III or Stage IV Melanoma | ||
| NCT03769558 | A Study of Juvenile Idiopathic Arthritis Patients Given Abatacept and the Number of Infections or Malignancies That Occur | ||
| NCT06544655 | A Study of BMS-986484 Alone and Combination Therapy in Participants With Advanced Solid Tumors | ||
| NCT04848116 | Neoadjuvant Targeting of Myeloid Cell Populations in Combination With Nivolumab in Head & Neck Ca | ||
| NCT01257204 | Study in Genotype 2 or 3 Patients With Chronic Hepatitis Virus Infection | ||
| NCT07018752 | A Platform Trial Evaluating New Drugs or Combination in R/R Peripheral T-cell Lymphomas | ||
| NCT04934696 | A Study to Characterize the Drug Levels of an Oral Contraceptive With and Without BMS-986166 in Healthy Female Participants of Childbearing Potential | ||
| NCT03554317 | COMbination of Bipolar Androgen Therapy and Nivolumab | ||
| NCT02450682 | Apixaban in Patients Who Undergo CIED Procedure- Randomized Pilot Study | ||
| NCT00225160 | ALCAR Prophylaxis Study | ||
| NCT01173120 | Methotrexate - Inadequate Response Device Sub-Study | ||
| NCT02738918 | Belatacept (Nulojix) in Renal Transplant Recipient With Mild Immunologic Risk Factor: a Pilot Prospective Study. | ||
| NCT00803374 | Combination of Anti-CD137 & Ipilimumab in Patients With Melanoma | ||
| NCT01086280 | Risk of Cardiovascular Events in Patients With Type 2 Diabetes Initiating Oral Antidiabetic Treatments | ||
| NCT00359450 | Study of BMS-275183 in Patients With Pretreated Locally Advanced or Metastatic NSCLC (Non Small Cell Lung Cancer) | ||
| NCT00501410 | FOLFOX Chemotherapy Regimen (5-FU, Leucovorin, Oxaliplatin) in Metastatic Colorectal Cancer | ||
| NCT01511913 | A Multi-National, Prospective, Observational Study in Patients With Unresectable or Metastatic Melanoma | ||
| NCT04877288 | A Study to Evaluate the Benefits and Risks of Conversion of Existing Adolescent Kidney Transplant Recipients Aged 12 to <18 Years to a Belatacept-based Immunosuppressive Regimen as Compared to Continuation of a Calcineurin Inhibitor-based Regimen, and Their Adherence to Immunosuppressive Medications | ||
| NCT03317327 | REirradiation and Programmed Cell Death Protein 1 (PD-1) Blockade On Recurrent Squamous Cell Head and Neck Tumors | ||
| NCT05048212 | A Phase II Study of Nivolumab With Ipilimumab and Cabozantinib in Patients With Untreated Renal Cell Carcinoma Brain Metastases | ||
| NCT05001087 | A "Physician & Patient-powered" Cohort Registry (MY MYELOMA) | ||
| NCT01629758 | Safety Study of IL-21/Anti-PD-1 Combination in the Treatment of Solid Tumors | ||
| NCT00455533 | Study to Assess Effectiveness of Giving Combination of Standard Chemotherapy Drugs Versus Combination of Standard Chemotherapy and New Drug Ixabepilone When Given Before Surgical Removal of Early Stage Breast Cancer | ||
| NCT02790125 | A Randomized, Double Blind Placebo-Controlled, Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BMS-986166 in Healthy Subjects | ||
| NCT06126224 | A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-2) | ||
| NCT02130817 | Belatacept in Kidney Transplantation of Moderately Sensitized Patients | ||
| NCT07763418 | A Study to Evaluate the Pharmacokinetics and Safety of Golcadomide in Participants With Severe Renal Impairment and End-Stage Renal Disease Compared With Participants With Normal Renal Function | ||
| NCT00106808 | Study of Muraglitazar Versus Pioglitazone in Type 2 Diabetes | ||
| NCT00000660 | Phase I Study of Weekly Oral VP-16 for AIDS-Associated Kaposi's Sarcoma | ||
| NCT05730725 | A Study to Evaluate Effectiveness and Safety of BMS-986322 in Participants With Moderate-to-Severe Psoriasis | ||
| NCT00787150 | A Phase 2 Study To Evaluate The Safety Of Apixaban In Atrial Fibrillation | ||
| NCT02655458 | Elotuzumab in Autologous Stem Cell Transplantation (ASCT) and Lenalidomide Maintenance for Multiple Myeloma | ||
| NCT00918385 | Genomic Guided Therapy With Dasatinib or Nilutamide in Metastatic Castration-Resistant Prostate Cancer | ||
| NCT04162015 | A Study of Nivolumab and Chemotherapy Followed by Surgery for Mesothelioma | ||
| NCT04876313 | An Open Label, Single-arm, Phase 2 Study of Neoadjuvant Nivolumab and Nab-paclitaxel Before Radical Cystectomy for Patients With Muscle-invasive Bladder Cancer (NURE-Combo) | ||
| NCT00895297 | Efficacy and Safety Study of Dasatinib in Patients With Chronic Myeloid Leukemia | ||
| NCT02170727 | A Phase 3 Study of a Daclatasvir/Asunaprevir/BMS-791325 Fixed Dose Combination (FDC) in Subjects With Chronic Hepatitis C Genotype 1 | ||
| NCT07271069 | Effectiveness of Ozanimod in Patients With Steroid-Dependent Ulcerative Colitis | ||
| NCT02733445 | Metabolic Outcomes in Patients Receiving Tyrosine Kinase Inhibitor (TKI) Therapy With Dasatinib or Nilotinib | ||
| NCT00944905 | Study of MDX-1203 in Subjects With Advanced/Recurrent Clear Cell Renal Cell Carcinoma (ccRCC) or Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (B-NHL) | ||
| NCT05625412 | A Study of BMS-986360/CC-90001 Alone and in Combination With Chemotherapy or Nivolumab in Advanced Solid Tumors | ||
| NCT01105429 | Single Ascending Dose Study of BMS-820132 in Patients With Type 2 Diabetes | ||
| NCT04631731 | Risk Factors of Immune-ChEckpoint Inhibitors MEdiated Liver, Gastrointestinal, Endocrine and Skin Toxicity | ||
| NCT05658601 | A Study to Describe the Switching From a First- or Second-line Disease Modifying Therapy (DMT) to Ozanimod in Participants With Relapsing Remitting Multiple Sclerosis (RRMS) |
